MPD: List measures where strain PWD/PhJ is an outlier

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.

List measures where PWD/PhJ is an outlier

Click on pulldowns below to see PWD/PhJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Ackert1:31	Ackert1	body size and weight	(none)	body mass index (BMI) [kg/m²] BMI 25031 6mo 12mo 20mo	inbred	32	both		N=7	2008

Ackert1:46	Ackert1	DXA	(none)	weight of lean tissue mass, head excluded [g] LTM 25046 6mo 12mo 20mo	inbred	32	both		N=7	2008

CGDpheno1:8	CGDpheno1	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 31808	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:56	CGDpheno1	metabolic panel	(none)	potassium (plasma K) [mmol/L] potassium 31856	inbred w/CC8	72	both	12wks	N=8	2009

Chen1:5	Chen1	immune cell quantification	(none)	peripheral blood to spleen ratio of invariant NK T cells [ratio] iNKT_pb_spl_ratio 52305	inbred	38	m	8-10wks	N=4	2011

Donahue4:1	Donahue4	open field test	(none)	total number of horizontal beam breaks, 10 min test [n] breaks_horiz 41301	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:3	Donahue4	open field test	(none)	duration of total horizontal activity, 10 min test [s] duration_horiz 41303	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:10	Donahue4	open field test	(none)	total number of vertical beam breaks, 10 min test [n] breaks_vert 41310	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:11	Donahue4	open field test	(none)	number of discrete vertical episodes, 10 min test [n] episode_vert 41311	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:12	Donahue4	open field test	(none)	duration of total vertical activity, 10 min test [s] duration_vert 41312	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:30	Donahue4	open field test	(none)	number of stereotypic beam breaks, repetitive activity, 10 min test [n] breaks_stereotypic 41330	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:31	Donahue4	open field test	(none)	number of discrete stereotypic episodes, repetitive activity, 10 min test [n] episode_stereotypic 41331	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue4:32	Donahue4	open field test	(none)	duration of stereotypic behavior, repetitive activity, 10 min test [s] duration_stereotypic 41332	B6.PWD consomic w/par	28	both	6wks	N=8	2011

Donahue6:1	Donahue6	immune cell quantification	(none)	neutrophil differential (percentage of viable WBC) [%] pct_NEUT 41501	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:6	Donahue6	immune cell quantification	(none)	B cells (percentage of viable WBC) [%] pct_B_cells 41506	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:7	Donahue6	immune cell quantification	(none)	natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_cells 41507	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:8	Donahue6	immune cell quantification	(none)	mature natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_mature 41508	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:9	Donahue6	immune cell quantification	(none)	T cells (percentage of viable WBC) [%] pct_T_cells 41509	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:10	Donahue6	immune cell quantification	(none)	CD4 T cells (percentage of viable WBC) [%] pct_CD4 41510	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue9:4	Donahue9	metabolic panel	(none)	magnesium (serum Mg) [mg/dL] magnesium 41804	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:8	Donahue9	metabolic panel	(none)	alkaline phosphatase (serum ALP) [IU/L] ALP 41808	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:9	Donahue9	metabolic panel	(none)	alanine transaminase (serum ALT) [IU/L] ALT 41809	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:10	Donahue9	metabolic panel	(none)	aspartate transaminase (serum AST) [IU/L] AST 41810	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:11	Donahue9	metabolic panel	(none)	lipase (serum LIP) [U/L] LIP 41811	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Johnson4:1	Johnson4	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 42601 click 8kHZ tone 16kHz tone 32kHz tone	B6.PWD consomic w/par	28	both	49-63wks	N=8	2012

Korstanje1:1	Korstanje1	urinalysis	(none)	microalbumin (urine MA) [mg/dL] MA 29701 12mo 18mo 24mo	inbred	30	both		N=7	2008

Korstanje1:21	Korstanje1	urinalysis	(none)	albumin-creatinine ratio (urine ACR) [mg/g] ACR 29721 12mo 18mo 24mo	inbred	30	both		N=7	2008

Kumar3:19	Kumar3	open field test	(none)	time spent grooming first 5 min [s] GrTime5m 112927	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:20	Kumar3	open field test	(none)	time spent grooming first 20 min [s] GrTime20m 112928	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:21	Kumar3	open field test	(none)	time spent grooming first 55 min [s] GrTime55m 112929	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:23	Kumar3	open field test	(none)	number of grooming events in first 5 min [n] GrBoutNum5m 112931	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:28	Kumar3	open field test	(none)	duration of grooming events first 20 min (s per event) [s/n] GrBoutLength20m 112936	inbred w/CC8	62	both	8-14wks	N=19	2021

Kumar3:29	Kumar3	open field test	(none)	duration of grooming events first 55 min (s per event) [s/n] GrBoutLength55m 112937	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar4:26	Kumar4	gait analysis	(none)	lateral distance separating hind paws (keypoints), mean [cm] step_width_mean 114456	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:27	Kumar4	gait analysis	(none)	lateral distance separating hind paws (keypoints), median [cm] step_width_median 114457	inbred w/CC8	62	both	10-20wks	N=19	2021

Lightfoot1:3	Lightfoot1	running wheel monitoring	(none)	wheel running activity, mean speed [m/min] activity_speed 35703	inbred	41	both	8-16wks	N=6	2010

Lightfoot1:80	Lightfoot1	colony observation	(none)	age at testing (local parameter) [d] age 35780	inbred	41	both		N=6	2010

Peters4:69	Peters4	complete blood count	(none)	mean RBC hemoglobin concentration (MCHC) [g/dL] MCHC 24369 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:46	Petkova1	immune cell quantification	(none)	CD4 T cells, effector, as percentage of total CD4 T cells [%] CD4_effector 24246 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:61	Petkova1	immune cell quantification	(none)	CD8 T cells, central memory, as percentage of total CD8 T cells [%] CD8_mem_central 24261 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:71	Petkova1	immune cell quantification	(none)	CD8 T cells, effector, as percentage of total CD8 T cells [%] CD8_effector 24271 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Seburn2:1	Seburn2	grip strength	(none)	grip strength, peak tension over 3 trials [g] grip_strength 24801 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2008

Svenson3:1	Svenson3	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 27301	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:2	Svenson3	complete blood count	(none)	red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 27302	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:3	Svenson3	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 27303	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:4	Svenson3	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYM 27304	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:6	Svenson3	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 27306	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:18	Svenson3	complete blood count	(none)	calculated hemoglobin (HGB) [g/dL] cHGB 27318	B6.PWD consomic w/par	27	both	7wks	N=8	2006

Svenson4:4	Svenson4	DXA	(none)	total body tissue mass, head excluded [g] total_wt 27404	B6.PWD consomic w/par	28	both	16wks	N=10	2006

Svenson4:5	Svenson4	DXA	(none)	lean body tissue mass, head excluded [g] lean_wt 27405	B6.PWD consomic w/par	28	both	16wks	N=9	2006

Svenson4:7	Svenson4	body size and weight	(none)	body weight [g] body_weight 27407	B6.PWD consomic w/par	28	both	16wks	N=10	2006

Svenson4:8	Svenson4	body size and weight	(none)	body length (tip of nose to base of tail) [cm] body_length 27408	B6.PWD consomic w/par	28	both	16wks	N=10	2006

Svenson4:9	Svenson4	DXA	(none)	total body area without head [cm²] total_area 27409	B6.PWD consomic w/par	28	both	16wks	N=10	2006

Svenson4:11	Svenson4	body size and weight	(none)	body mass index (BMI) [kg/m²] BMI 27411	B6.PWD consomic w/par	28	both	16wks	N=10	2006

Tarantino1:5	Tarantino1	open field test	cocaine	ambulatory episodes, 30 min test [n] amb_epi 45916 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino1:8	Tarantino1	open field test	cocaine	rearing episodes, 30 min test [n] rear 45921 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino1:11	Tarantino1	open field test	cocaine	average velocity, 30 min test [cm/s] vel 45926 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Wiltshire4:1	Wiltshire4	immune cell quantification	BEZ235	B cells, percent viability [%] Bcells_BEZ 52401 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:21	Wiltshire4	immune cell quantification	doxorubicin	B cells, percent viability [%] Bcells_Dox 52421 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:41	Wiltshire4	immune cell quantification	idarubicin	B cells, percent viability [%] Bcells_Ida 52441 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:61	Wiltshire4	immune cell quantification	selumetinib	B cells, percent viability [%] Bcells_Sel 52461 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:73	Wiltshire4	immune cell quantification	selumetinib	monocytes, percent viability [%] monocytes_Sel 52473 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Xing1:21	Xing1	ECG	(none)	interval PR [ms] PR 24921 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:26	Xing1	ECG	(none)	interval QRS [ms] QRS 24926 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:31	Xing1	ECG	(none)	interval QT [ms] QT 24931 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:41	Xing1	ECG	(none)	interval ST [ms] ST 24941 6mo 12mo 20mo	inbred	29	both		N=7	2008

Yuan3:1	Yuan3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 24401 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:11	Yuan3	metabolic panel	(none)	alkaline phosphatase (serum ALP) [IU/L] ALP 24411 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:81	Yuan3	metabolic panel	(none)	blood urea nitrogen (plasma BUN) [mg/dL] BUN 24481 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan4:2	Yuan4	colony observation	(none)	age at vaginal opening (patency) [d] age_VO 25402	inbred	33	f	2-7wks	N=38	2009

An error occurred on this page.These results could be incomplete or invalid. Staff have been notified.

List measures where PWD/PhJ is an outlier

Filter Table Results

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.